(Q55003988)

15 June 2018

title

Evaluation of PIK3CA mutations as a biomarker in Chinese breast carcinomas from Western China. (English)

1 reference

15 June 2018

0 references

4

1 reference

15 June 2018

Md. Asaduzzaman Khan

5

1 reference

15 June 2018

Hanchun Chen

object named as

Hanchun Chen

8

1 reference

ORCID Public Data File 2021

author name string

Jingliang Cheng

1

1 reference

15 June 2018

Shangyi Fu

2

1 reference

15 June 2018

Chunli Wei

3

1 reference

15 June 2018

Saber Imani

6

1 reference

15 June 2018

Baixu Zhou

7

1 reference

15 June 2018

Xiuli Xiao

9

1 reference

15 June 2018

Jingbo Wu

10

1 reference

15 June 2018

Junjiang Fu

11

1 reference

15 June 2018

publication date

1 January 2017

1 reference

15 June 2018

published in

Cancer Biomarkers

1 reference

15 June 2018

volume

19

1 reference

15 June 2018

issue

1

1 reference

15 June 2018

page(s)

85-92

1 reference

15 June 2018

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

cites work

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

The phosphoinositide 3-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

PIK3CA mutations in breast cancer are associated with poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

High frequency of mutations of the PIK3CA gene in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

Rapid detection of genetic mutations in individual breast cancer patients by next-generation DNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

Prognostic Value of EMT-inducing Transcription Factors (EMT-TFs) in Metastatic Breast Cancer: A Systematic Review and Meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

21 January 2018

Breast cancer in China

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

PIK3CA and TP53 gene mutations in human breast cancer tumors frequently detected by ion torrent DNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

Breast cancer care in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

Environmental pollutants, diet, physical activity, body size, and breast cancer: where do we stand in research to identify opportunities for prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

TWIST represses estrogen receptor-alpha expression by recruiting the NuRD protein complex in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

Relationship between SPOP mutation and breast cancer in Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

An integrative analysis of PIK3CA mutation, PTEN, and INPP4B expression in terms of trastuzumab efficacy in HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

Relationship of PIK3CA mutation and pathway activity with antiproliferative response to aromatase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

Molecular cloning, cDNA sequence, and chromosomal localization of the human phosphatidylinositol 3-kinase p110 alpha (PIK3CA) gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

Somatic mutation and gain of copy number of PIK3CA in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

The PIK3CA gene is mutated with high frequency in human breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

Mutation distributions and clinical correlations of PIK3CA gene mutations in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

DLX4 upregulates TWIST and enhances tumor migration, invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

Targeted next-generation sequencing detects a high frequency of potentially actionable mutations in metastatic breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

PIK3CA mutation associates with improved outcome in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

Somatic mutation profiling and associations with prognosis and trastuzumab benefit in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

PIK3CA mutations are associated with decreased benefit to neoadjuvant human epidermal growth factor receptor 2-targeted therapies in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

First-in-human phase I study of pictilisib (GDC-0941), a potent pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FCBM-160380

21 January 2018

Identifiers

DOI

10.3233/CBM-160380

1 reference

15 June 2018

PubMed ID

28269754

1 reference

15 June 2018